Securing Critical Medical Supply for the West.

Partner with Genhtis Join the mission
Mission

Essential medicines require essential infrastructure.

Genhtis exists to secure the supply of critical pharmaceuticals for Western healthcare systems. We are building infrastructure-grade manufacturing capacity for medicines that hospitals cannot operate without.

Supply security is not a logistics problem. It is a strategic imperative.

The Challenge

Western healthcare depends on fragile supply chains.

01

Concentration Risk

Critical pharmaceutical ingredients are sourced from a small number of regions. A single disruption can cascade across entire healthcare systems.

02

No Strategic Reserve

Most essential medicines have no domestic or allied-nation manufacturing base. Stockpiles are measured in weeks, not months.

03

Systemic Vulnerability

Geopolitical tension, trade restrictions, and quality incidents have already caused shortages. The risk profile is increasing.

Our Approach

Infrastructure-grade manufacturing. Built for resilience.

Vertically Integrated

Genhtis controls the full manufacturing chain. From raw input to finished pharmaceutical product, every step is secured and auditable.

Western-Based Production

Manufacturing facilities located in allied nations. No dependency on adversarial or unstable supply corridors.

Scalable by Design

Modular manufacturing architecture enables rapid capacity expansion. Built to meet surge demand when continuity matters most.

First Focus

Heparin.

Heparin is one of the most widely used anticoagulants in modern medicine. It is essential for cardiac surgery, dialysis, trauma care, and critical interventions across every major hospital system. Today, the global supply of heparin raw material is concentrated in a single region, creating a strategic vulnerability that affects millions of patients annually.

Genhtis has selected heparin as its first critical medicine. A proven need. A clear vulnerability. A solvable problem.

Learn more
Heparin Molecule Render
Security of Supply

Four pillars of supply resilience.

Redundancy

Multiple production pathways eliminate single points of failure across the supply chain.

Quality

Pharmaceutical-grade standards at every manufacturing stage. Full regulatory compliance from day one.

Traceability

End-to-end chain of custody. Every input tracked, every output verified, every batch auditable.

Scalability

Modular architecture designed to scale capacity in response to demand and strategic need.

Trusted By
Partnerships

Strategic partnerships accelerate the mission.

Government and Public Sector

Build sovereign pharmaceutical manufacturing capacity and strengthen national health security.

Explore partnership →

Pharma and CDMO Partners

Collaborate on manufacturing scale-up, quality systems, and supply chain integration.

Start a conversation →

Health Systems and Procurement

Secure a diversified, traceable supply of essential medicines for your hospital network.

Discuss supply security →
Careers

The mission requires exceptional people.

Genhtis is assembling a team of scientists, engineers, manufacturing experts, and strategists. If you build critical systems and want your work to matter, we want to hear from you.

Science

Bioprocess Scientists

Lead development and optimization of manufacturing processes for critical pharmaceutical products.

Engineering

Manufacturing Engineers

Design and scale infrastructure-grade production systems from pilot to commercial capacity.

Quality

Quality and Regulatory

Build quality systems that meet the highest pharmaceutical standards across multiple jurisdictions.

Operations

Supply Chain and Strategy

Architect resilient supply networks and drive strategic partnerships across government and industry.

Join the team
Insights

Analysis and perspective.

Supply Security

The Case for Sovereign Pharmaceutical Manufacturing

Western healthcare systems face a structural dependency on concentrated supply chains for critical medicines.

2026
Heparin

Heparin: A Critical Medicine at Risk

Heparin is essential, irreplaceable at scale, and dangerously concentrated. Understanding the risk is the first step.

2026
Infrastructure

Building Manufacturing as National Infrastructure

Pharmaceutical production for essential medicines should be treated with the same strategic seriousness as defence and energy.

2026

Pharmaceutical supply security is a strategic imperative.

Genhtis is building the infrastructure. Join us.

Partner with Genhtis Join the mission
Contact

Get in touch.

Genhtis welcomes inquiries from government stakeholders, pharmaceutical partners, health systems, investors, and prospective team members.

info@genhtis.com